NoAAC surgeons debate treatment options in iSGS

Jun 16, 2018

244

NoAAC surgeons debate treatment options in iSGS 
Alexander Gelbard, Guri Sandhu, Jan Kasperbauer, and Rob Lorenz discuss the different treatments available for idiopathic subglottic stenosis at the World Congress for Bronchoesophagology in Rochester Minnesota.

Kat, Sharon, and 1 other like this.

1 comment

Join the conversation!Sign In

Linda ChappellBacker

Research papers in 2017 / 2018 by Franco et al, Bertelsen et al, Hoffman et al, show some positive results from awake intralesional steroid injections. What was the response of panel members to the potential use of awake ILSI if this was discussed at conference 16 June 2018? By the way, the panel line up is a patients dream team of world leading experts in one room, thank you all for your commitment! From a grateful patient, Liverpool, England.

Jun 19, 20180

About This Project

NoAAC Longitudinal Registry of Treatment Outcomes in iSGS

North American Airway Collaborative

Idiopathic subglottic stenosis (iSGS) is a rare and life-threatening disease involving airway obstruction. Given its rarity, a number of options for treatment have been developed. The proposed study will continue and extend the PCORI-funded study in iSGS conducted by the North American Airway Collaborative (NoAAC) to collect objective long-term data on outcomes and side effects. This information is critical to help patients decide on the best treatment.